Kirchner Group Advises Investor in $700M Financing in the BioTech Sector

26 June 2020 – Kirchner Group is pleased to announce that it acted as an advisor on due diligence to the Alaska Permanent Fund (represented by Crestline Investors) in the recently announced Sana Biotechnology $700M initial financing.

According to the announcement Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. They share a vision of repairing and controlling genes, replacing missing or damaged cells, and making their therapies broadly available to patients. Their team consists of 200 plus scientists, engineers, clinicians and biotechnology veterans creating an enduring company that makes meaningful medicines and changes how we approach treating disease. Sana has operations in Seattle, Cambridge, and South San Francisco.

“It is an honor to be the go to group to assist numerous investors in highly technical and scientific diligence for groundbreaking companies like Sana,” stated Blair Kirchner, Managing Director of Kirchner Group. “Our network and unique platform enable us to provide rapid and insightful input to investors around the world.”

Kirchner Group is also proud to note their previous similar roles in the  Denali Therapeutics (NASDAQ: DNLI), Juno Therapeutics (acquired by Celgene for approx. $9B) and Indigo Agriculture financings.

[k]

Kirchner Group

Kirchner Group was founded in 1985 as a boutique advisory firm and today operates various subsidiaries, providing advisory services (M&A, assessments, diligence) and operational support (interim management, workouts, turnarounds) as well as asset management (dedicated, portfolio optimization) – all leveraging a proprietary approach that dovetails domain and process expertise.

Throughout the decades Kirchner Group has been internationally recognized for its unique business model centered around creating value while promoting values: “earning while returning”. The firm has also established a reputation for building and rebuilding important business and social paradigms based on its deep entrepreneurial orientation.

Kirchner Group’s clients and partners include early stage to mid-market companies, venture capital and private equity firms as well as family offices and some of the world’s largest insurance companies, commercial banks and institutional investors. www.kirchnergroup.com

Blair Kirchner | Managing Director & Co-Head of Impact Activities |Kirchner Group | bgkirchner@kirchnergroup.com